Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice

Neurobiology of Aging

Volumn 22, Issue 6, 2001, Pages 983-991

  Lim, G P ^a   Yang, F ^a   Chu, T ^a   Gahtan, E ^b   Ubeda, O ^a   Beech, W ^a   Overmier, J B ^b   Hsiao Ashec, K ^b   Frautschy, S A ^a   Cole, G M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alzheimer; Carbonyl; Caspase; Females; Interleukin 1 ; Neuroinflammation; Neuroprotection; NSAIDs; Open field activity; Oxidative damage; Tg2576; Ubiquitin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CASPASE; IBUPROFEN; INTERLEUKIN 1BETA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENTORHINAL CORTEX; ENZYME ACTIVATION; FEMALE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OPEN FIELD BEHAVIOR; OXIDATION; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TRANSGENIC MOUSE; TREATMENT OUTCOME;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IBUPROFEN; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MALE; MICE; MICE, TRANSGENIC; OXIDATION-REDUCTION; SEX CHARACTERISTICS;

EID: 0035691115     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00299-8     Document Type: Article

References (38)

1. Inflammation and Alzheimer's disease
2. Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid
3. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs
4. Effect of chloroquine and leupeptin on intracellular accumulation of amyloid-beta (Aβ) 1-42 peptide in a murine N9 microglial cell line
5. An endosomal lysosomal pathway for degradation of amyloid precursor protein
6. Accumulation of amyloid precursor protein fragment in Alzheimer plaques
7. Caspase activation in dystrophic neurites in Alzheimer's disease and aged huAPPsw transgenic mice
8. Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies
9. Microglial response to amyloid plaques in APPsw transgenic mice
10. Involvement of free oxygen radicals in β-amyloidosis: An hypothesis
11. Inflammatory pathogenesis in Alzheimer's disease: Biological mechanisms and cogitive sequeli
12. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic A beta peptide
13. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells
14. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
15. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
16. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice
17. NSAIDs and incidence Alzheimer's disease. The Rotterdam study
18. sw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1
19. Modification of microglial reactivity in MAPP/MPS1 transgenic mice using NCX-2216 (nitroflurbiprofen)
20. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease
21. Progressive and gender-dependent cognitive impairment in the APPsw transgenic mouse model for Alzheimer's disease
22. Hippocampal morphology and open-field behavior in Mus musculus domesticus and Mus spretus inbred mice
23. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
24. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
25. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease
26. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
27. A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor
28. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease
29. Polyclonals to β-amyloid (1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum
30. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
31. The spectrum of behavioral changes in Alzheimer's disease
32. High-level neuronal expression of Abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation
33. Inhibition of Alzheimer β-fibrillogensis by melatonin
34. Inflammation and Alzheimer's Disease Pathogenesis
35. Risk of Alzheimer's disease and duration of NSAID use
36. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain
37. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and neurons and plaque associated neurons and microglia in Alzheimer's disease